SlideShare a Scribd company logo
+
SAFTINet Cardiovascular
Cohort PRO: Medication
Adherence
CER Team
2 July 2012
+
Overview
 PEC preference regarding the medication adherence measure
 Instrument
 Pilot test
 Feedback on the instrument
 Feedback on the pilot
 How would we use the findings in our research?
+
Overview
 PEC preference regarding the medication adherence measure
 Instrument
 Pilot test
 Feedback on the instrument
 Feedback on the pilot
 How would we use the findings in our research?
+
Proposed Med Adherence Instrument
and Pilot Test
 A single medication adherence question (derived from the Gehi
question) and a single checklist of barriers
 Pilot test by 1-2 providers in each organization for a few weeks
+
Proposed Med Adherence Instrument:
Adherence Question
 Patient Instructions:
 It can be difficult to take all of our medications as the doctor has told
us to. Please tell us how often taking your medications is difficult for
you.
 In the past month, how often did you take your medications as the
doctor or provider prescribed?1 Please check one (1) answer.
 “All of the time” (100%)
 “Nearly all of the time” (90%)
 “Most of the time” (75%)
 “About half the time” (50%)
 “Less than half the time” (<50%)
 “None of the time” (0%)
+
Proposed Med Adherence Instrument:
Barriers Checklist
 In the past month, why have you not taken your medicine as
your doctor prescribed? Check all that apply.
 My medicine makes me feel bad (I have “side effects”). Please
describe: ________________
 I don’t feel like my medicine is working
 I feel like taking my medicine will not improve my health
 There are too many doses of medicine to take each day
 I cannot afford my medicine
 I forget to take my medicine
+
Proposed Med Adherence
Instrument: Barriers Checklist
 Domains for Barriers:
 Side effects
 No improvement in symptoms
 Belief medication won’t change outcomes
 Complexity of regimen
 Financial cost
 Forgetting
 Some options for wording on next slides
+
Proposed Med Adherence
Instrument: Barriers Checklist
 Domain for Barriers: Side effects
 Options
 proposed: My medicine makes me feel bad (I have “side effects”).
Please describe: ________________
 ASK-12: Have you skipped or stopped taking a medicine because it
made you feel bad?
 Morisky-8: Have you ever cut back or stopped taking your medicine
without telling your doctor because you felt worse when you took it?
 Morisky-4: At times, if you feel worse if you take your medicines, do
you stop taking them?
+
Proposed Med Adherence
Instrument: Barriers Checklist
 Domain for Barriers: No improvement in symptoms
 Options
 proposed: I don’t feel like my medicine is working
 ASK-12:
 I feel confident that each one of my medicines will help me
 Have you skipped or stopped taking a medicine because you did
not think it was working?
+
Proposed Med Adherence
Instrument: Barriers Checklist
 Domain for Barriers: Belief medication won’t change outcomes
 Options
 proposed: I feel like taking my medicine will not improve my health
 ASK-12:
 I feel confident that each one of my medicines will help me
 Have you skipped or stopped taking a medicine because you did
not think it was working?
+
Proposed Med Adherence Instrument:
Barriers Checklist
 Domain for Barriers: Complexity of regimen
 Options
 proposed: There are too many doses of medicine to take each day
 ASK-12: Taking medicines more than once a day is inconvenient
+
Proposed Med Adherence Instrument:
Barriers Checklist
 Domain for Barriers: Financial cost
 Options
 proposed: I cannot afford my medicine
 ASK-12:
 I feel confident that each one of my medicines will help me
 Have you skipped, stopped, not refilled, or taken less medicine
because of the cost?
+
Proposed Med Adherence Instrument:
Barriers Checklist
 Domain for Barriers: Forgetting
 Options
 proposed: I forget to take my medicine
 ASK-12:
 I just forget to take my medicines some of the time
 I run out of my medicine because I don’t get refills on time
 Morisky-8:
 Do you sometimes forget to take your pills?
 How often do you have difficulty remembering to take all your
medications?
 When you travel or leave home do you sometimes forget to bring
your medicine?
 Morisky-4: Have you ever forgotten to take your medicine?
+
Med Adherence Instrument: Provider
Guidance, 1st slide
 Provider Instructions: Please review the patient’s responses and
considering adjusting the treatment plan if patients exhibit difficulty
taking their medications. Encouraging adherence to medications is
one of the best ways to improve outcomes! Some ideas for helping
patients take their medications include:
 Side effects: Switch medications, adjust the dose, or recommend
other mitigation strategies (e.g., taking the medication with food,
reducing salt intake)
 Feeling as though the medication does not or will not improve their
health: indicate a range of time before seeing results, encourage
logging or home monitoring (e.g., blood pressure) so patients can
see change
+
Med Adherence Instrument: Provider
Guidance, 2nd slide
 Complex regimens: Consider reducing medications, use
combination therapies, design a treatment plan that is easier to
follow (e.g., all medications should be taken in the morning),
use organizing systems (pillboxes)
 Cost: Switch to lower cost medications, facilitate sign-up for
prescription assistance plans
 Forgetting: Encourage routines, pairing medications with other
daily activities, use of memory aids (alarms, pillboxes,
calendars), use health IT tools to remind patients to proactively
refill prescriptions
+
Pilot Timeline
 July 10, 2012: Feedback from PEC partners on summary of the
instrument
 July 20, 2102: Spanish translation of instrument completed
 July 20, 2012: Partners’ providers for Pilot Test identified
 Aug 1, 2012: PEC and providers participating in Pilot meet at
regularly scheduled PEC meeting
 Aug 1, 2012: Feedback questionnaires provided to PEC
partners
 Aug 13, 2012: Feedback questionnaires returned to SAFTINet
research team
+
Pilot Survey, 1st slide
 Is the information in the survey useful to you as a clinical
provider? Are there questions that are not useful? Are there
questions that would be really useful to you that are missing?
 Do the respondents feel comfortable answering the questions?
 Is the wording of the survey clear? Are there questions that
respondents consistently misunderstand? Is there some
wording that needs to be changed? Do you have suggestions
for better wording?
 How long does this survey take to administer?
+
Pilot Survey, 2nd slide
 Is the survey too long? If so, what question(s) do you suggest we
drop? Is there a question we are missing?
 Are the “provider instructions” about how to adjust the treatment
plan helpful to you? Are they too common-sense? Are they too
context-dependent (would be different at different practice sites)?
 Did it make sense to administer this survey at the patient’s visit to
the clinic? Would it be better administered by phone or by other
strategies? If so, how do you suggest we administer it?
 Do you prefer to administer the survey to all patients? To only
patients with hyperlipidemia or hypertension?
+
Overview
 PEC preference regarding the medication adherence measure
 Instrument
 Pilot test
 Feedback on the instrument
 Feedback on the pilot
 How would we use the findings in our research?
+
Overview
 PEC preference regarding the medication adherence measure
 Instrument
 Pilot test
 Feedback on the instrument
 Feedback on the pilot
 How would we use the findings in our research?
+
Research Utility
 Which domains would we use?
 medication adherence scale
 barriers measure total count, or focus on specific barrier(s)
 How would we use these in an analytic model?
PCMH
Medication adherence
Barriers
Disease control

More Related Content

What's hot

The Pharmacist's Challenge
The Pharmacist's ChallengeThe Pharmacist's Challenge
The Pharmacist's Challenge
e-SupplyLink
 
Communicating prescribing decisions v1.4
Communicating prescribing decisions v1.4Communicating prescribing decisions v1.4
Communicating prescribing decisions v1.4
Sabih Huq
 
Changing treatment and drug resistance
Changing treatment and drug resistanceChanging treatment and drug resistance
Changing treatment and drug resistance
ITPCMENA
 
Digital Leadership: An interview with Bernard Vrijens Chief Science Officer, ...
Digital Leadership: An interview with Bernard Vrijens Chief Science Officer, ...Digital Leadership: An interview with Bernard Vrijens Chief Science Officer, ...
Digital Leadership: An interview with Bernard Vrijens Chief Science Officer, ...
Capgemini
 
Medication reconciliation
Medication reconciliationMedication reconciliation
Medication reconciliation
wcmc
 
Week 7 interviewing and assessement
Week 7 interviewing and assessementWeek 7 interviewing and assessement
Week 7 interviewing and assessement
College of Pharmacy University of Sulaimani
 
Medication Reconciliation
Medication ReconciliationMedication Reconciliation
Medication Reconciliation
PAFP
 
CCK Dashboard 2019: Pharmaceutical Manufacturing & Great Expectations
CCK Dashboard 2019: Pharmaceutical Manufacturing & Great ExpectationsCCK Dashboard 2019: Pharmaceutical Manufacturing & Great Expectations
CCK Dashboard 2019: Pharmaceutical Manufacturing & Great Expectations
Obaid Ali / Roohi B. Obaid
 
Peer2Peer Module 3 Training
Peer2Peer Module 3 TrainingPeer2Peer Module 3 Training
Peer2Peer Module 3 Training
Kimberly Martin
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
MayuriChichoundikar
 
Medicines Reconciliation Needs You!
Medicines Reconciliation Needs You!Medicines Reconciliation Needs You!
Medicines Reconciliation Needs You!
NHSScotlandEvent
 

What's hot (11)

The Pharmacist's Challenge
The Pharmacist's ChallengeThe Pharmacist's Challenge
The Pharmacist's Challenge
 
Communicating prescribing decisions v1.4
Communicating prescribing decisions v1.4Communicating prescribing decisions v1.4
Communicating prescribing decisions v1.4
 
Changing treatment and drug resistance
Changing treatment and drug resistanceChanging treatment and drug resistance
Changing treatment and drug resistance
 
Digital Leadership: An interview with Bernard Vrijens Chief Science Officer, ...
Digital Leadership: An interview with Bernard Vrijens Chief Science Officer, ...Digital Leadership: An interview with Bernard Vrijens Chief Science Officer, ...
Digital Leadership: An interview with Bernard Vrijens Chief Science Officer, ...
 
Medication reconciliation
Medication reconciliationMedication reconciliation
Medication reconciliation
 
Week 7 interviewing and assessement
Week 7 interviewing and assessementWeek 7 interviewing and assessement
Week 7 interviewing and assessement
 
Medication Reconciliation
Medication ReconciliationMedication Reconciliation
Medication Reconciliation
 
CCK Dashboard 2019: Pharmaceutical Manufacturing & Great Expectations
CCK Dashboard 2019: Pharmaceutical Manufacturing & Great ExpectationsCCK Dashboard 2019: Pharmaceutical Manufacturing & Great Expectations
CCK Dashboard 2019: Pharmaceutical Manufacturing & Great Expectations
 
Peer2Peer Module 3 Training
Peer2Peer Module 3 TrainingPeer2Peer Module 3 Training
Peer2Peer Module 3 Training
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
 
Medicines Reconciliation Needs You!
Medicines Reconciliation Needs You!Medicines Reconciliation Needs You!
Medicines Reconciliation Needs You!
 

Viewers also liked

Thong ke xo so mien bac 10 ngay
Thong ke xo so mien bac 10 ngayThong ke xo so mien bac 10 ngay
Thong ke xo so mien bac 10 ngay
bang xep hang bong da
 
Ijm 06 09_012
Ijm 06 09_012Ijm 06 09_012
Ijm 06 09_012
IAEME Publication
 
IoT_Implemented
IoT_ImplementedIoT_Implemented
IoT_Implemented
Brandon Walston
 
Surya ppt
Surya pptSurya ppt
Surya ppt
shareenapr5
 
Individual treatment tom
Individual treatment tomIndividual treatment tom
Individual treatment tom
rhsmediastudies
 
Ijeet 06 08_008
Ijeet 06 08_008Ijeet 06 08_008
Ijeet 06 08_008
IAEME Publication
 
Trabajo en clase 1
Trabajo en clase 1Trabajo en clase 1
Trabajo en clase 1
Visual Sonica
 
Sp ref en
Sp ref enSp ref en
Sp ref en
fapac
 
Power Point Presentation
Power Point Presentation Power Point Presentation
Power Point Presentation
Arun Murali
 
Sights of London
Sights of LondonSights of London
Sights of London
YanaBakum
 
10-11. Пересування по скельному рельєфу, спорядження, страховка.
10-11. Пересування по скельному рельєфу, спорядження, страховка.10-11. Пересування по скельному рельєфу, спорядження, страховка.
10-11. Пересування по скельному рельєфу, спорядження, страховка.
Сергій Федірко
 
Genre Assignment - Cult Classics Presentation
Genre Assignment - Cult Classics PresentationGenre Assignment - Cult Classics Presentation
Genre Assignment - Cult Classics Presentation
Fionnuala Mc Cann
 
ND Trishna
ND TrishnaND Trishna
ND Trishna
Trishna Misra
 
Ijmet 06 10_010
Ijmet 06 10_010Ijmet 06 10_010
Ijmet 06 10_010
IAEME Publication
 
Ijciet 06 09_017
Ijciet 06 09_017Ijciet 06 09_017
Ijciet 06 09_017
IAEME Publication
 
Ijcet 06 10_002
Ijcet 06 10_002Ijcet 06 10_002
Ijcet 06 10_002
IAEME Publication
 
diff. of functions
diff. of functionsdiff. of functions
diff. of functions
Elias Dinsa
 

Viewers also liked (17)

Thong ke xo so mien bac 10 ngay
Thong ke xo so mien bac 10 ngayThong ke xo so mien bac 10 ngay
Thong ke xo so mien bac 10 ngay
 
Ijm 06 09_012
Ijm 06 09_012Ijm 06 09_012
Ijm 06 09_012
 
IoT_Implemented
IoT_ImplementedIoT_Implemented
IoT_Implemented
 
Surya ppt
Surya pptSurya ppt
Surya ppt
 
Individual treatment tom
Individual treatment tomIndividual treatment tom
Individual treatment tom
 
Ijeet 06 08_008
Ijeet 06 08_008Ijeet 06 08_008
Ijeet 06 08_008
 
Trabajo en clase 1
Trabajo en clase 1Trabajo en clase 1
Trabajo en clase 1
 
Sp ref en
Sp ref enSp ref en
Sp ref en
 
Power Point Presentation
Power Point Presentation Power Point Presentation
Power Point Presentation
 
Sights of London
Sights of LondonSights of London
Sights of London
 
10-11. Пересування по скельному рельєфу, спорядження, страховка.
10-11. Пересування по скельному рельєфу, спорядження, страховка.10-11. Пересування по скельному рельєфу, спорядження, страховка.
10-11. Пересування по скельному рельєфу, спорядження, страховка.
 
Genre Assignment - Cult Classics Presentation
Genre Assignment - Cult Classics PresentationGenre Assignment - Cult Classics Presentation
Genre Assignment - Cult Classics Presentation
 
ND Trishna
ND TrishnaND Trishna
ND Trishna
 
Ijmet 06 10_010
Ijmet 06 10_010Ijmet 06 10_010
Ijmet 06 10_010
 
Ijciet 06 09_017
Ijciet 06 09_017Ijciet 06 09_017
Ijciet 06 09_017
 
Ijcet 06 10_002
Ijcet 06 10_002Ijcet 06 10_002
Ijcet 06 10_002
 
diff. of functions
diff. of functionsdiff. of functions
diff. of functions
 

Similar to Med adherence 2 july 2012

Optimize Presentation
Optimize PresentationOptimize Presentation
Optimize Presentation
aaltunalboro
 
Med adherence and self efficacy
Med adherence and self efficacyMed adherence and self efficacy
Med adherence and self efficacy
Marion Sills
 
Med adherence and self efficacy
Med adherence and self efficacyMed adherence and self efficacy
Med adherence and self efficacy
Marion Sills
 
Medication Adherence.pptx
Medication Adherence.pptxMedication Adherence.pptx
Medication Adherence.pptx
NasserSalah6
 
Medication Adherence.pptx
Medication Adherence.pptxMedication Adherence.pptx
Medication Adherence.pptx
NasserSalah6
 
1. Pharmacists in patient care.pptx
1. Pharmacists in patient care.pptx1. Pharmacists in patient care.pptx
1. Pharmacists in patient care.pptx
yohanneswobie2
 
Medical history interview
Medical history interview Medical history interview
Medical history interview
Harshita Jain
 
1 The pharmacist’s Role in Self Care.pptx
1 The pharmacist’s Role in Self Care.pptx1 The pharmacist’s Role in Self Care.pptx
1 The pharmacist’s Role in Self Care.pptx
DrAllaAddinAlsyany
 
Project Overview
Project OverviewProject Overview
Project Overview
aaltunalboro
 
Patient Medication History
Patient Medication HistoryPatient Medication History
Patient Medication History
MadhukarSureshThagna
 
Team based opioid management - talking points
Team based opioid management - talking pointsTeam based opioid management - talking points
Team based opioid management - talking points
Paul Coelho, MD
 
Drugs Education.pptx
Drugs Education.pptxDrugs Education.pptx
Drugs Education.pptx
JamesJudeMirabueno1
 
Oral Chemotherapy Adherence
Oral Chemotherapy AdherenceOral Chemotherapy Adherence
Oral Chemotherapy Adherence
Alicia Vautour
 
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPMMEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
Lipanjali Badhei
 
Workshop 2: Benchmarking solutions showcase
Workshop 2: Benchmarking solutions showcaseWorkshop 2: Benchmarking solutions showcase
Workshop 2: Benchmarking solutions showcase
aaltunalboro
 
Clinical Research in CAM: Requirements, Complexities and Possibilities
Clinical Research in CAM: Requirements,  Complexities and PossibilitiesClinical Research in CAM: Requirements,  Complexities and Possibilities
Clinical Research in CAM: Requirements, Complexities and Possibilities
Ayurveda Network, BHU
 
Empowered Use, Health Consciousness and Prescription Drugs with Special Focus...
Empowered Use, Health Consciousness and Prescription Drugs with Special Focus...Empowered Use, Health Consciousness and Prescription Drugs with Special Focus...
Empowered Use, Health Consciousness and Prescription Drugs with Special Focus...
HPCareer.Net / State of Wellness Inc.
 
What Clinical Research Means to You: San Francisco AWARE FOR ALL
What Clinical Research Means to You: San Francisco AWARE FOR ALLWhat Clinical Research Means to You: San Francisco AWARE FOR ALL
What Clinical Research Means to You: San Francisco AWARE FOR ALL
CTSI at UCSF
 
Strategies to improve adherence to antihypertensive medication
Strategies to improve adherence to antihypertensive medicationStrategies to improve adherence to antihypertensive medication
Strategies to improve adherence to antihypertensive medication
magdy elmasry
 
Hta basic introduction
Hta basic introductionHta basic introduction

Similar to Med adherence 2 july 2012 (20)

Optimize Presentation
Optimize PresentationOptimize Presentation
Optimize Presentation
 
Med adherence and self efficacy
Med adherence and self efficacyMed adherence and self efficacy
Med adherence and self efficacy
 
Med adherence and self efficacy
Med adherence and self efficacyMed adherence and self efficacy
Med adherence and self efficacy
 
Medication Adherence.pptx
Medication Adherence.pptxMedication Adherence.pptx
Medication Adherence.pptx
 
Medication Adherence.pptx
Medication Adherence.pptxMedication Adherence.pptx
Medication Adherence.pptx
 
1. Pharmacists in patient care.pptx
1. Pharmacists in patient care.pptx1. Pharmacists in patient care.pptx
1. Pharmacists in patient care.pptx
 
Medical history interview
Medical history interview Medical history interview
Medical history interview
 
1 The pharmacist’s Role in Self Care.pptx
1 The pharmacist’s Role in Self Care.pptx1 The pharmacist’s Role in Self Care.pptx
1 The pharmacist’s Role in Self Care.pptx
 
Project Overview
Project OverviewProject Overview
Project Overview
 
Patient Medication History
Patient Medication HistoryPatient Medication History
Patient Medication History
 
Team based opioid management - talking points
Team based opioid management - talking pointsTeam based opioid management - talking points
Team based opioid management - talking points
 
Drugs Education.pptx
Drugs Education.pptxDrugs Education.pptx
Drugs Education.pptx
 
Oral Chemotherapy Adherence
Oral Chemotherapy AdherenceOral Chemotherapy Adherence
Oral Chemotherapy Adherence
 
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPMMEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
 
Workshop 2: Benchmarking solutions showcase
Workshop 2: Benchmarking solutions showcaseWorkshop 2: Benchmarking solutions showcase
Workshop 2: Benchmarking solutions showcase
 
Clinical Research in CAM: Requirements, Complexities and Possibilities
Clinical Research in CAM: Requirements,  Complexities and PossibilitiesClinical Research in CAM: Requirements,  Complexities and Possibilities
Clinical Research in CAM: Requirements, Complexities and Possibilities
 
Empowered Use, Health Consciousness and Prescription Drugs with Special Focus...
Empowered Use, Health Consciousness and Prescription Drugs with Special Focus...Empowered Use, Health Consciousness and Prescription Drugs with Special Focus...
Empowered Use, Health Consciousness and Prescription Drugs with Special Focus...
 
What Clinical Research Means to You: San Francisco AWARE FOR ALL
What Clinical Research Means to You: San Francisco AWARE FOR ALLWhat Clinical Research Means to You: San Francisco AWARE FOR ALL
What Clinical Research Means to You: San Francisco AWARE FOR ALL
 
Strategies to improve adherence to antihypertensive medication
Strategies to improve adherence to antihypertensive medicationStrategies to improve adherence to antihypertensive medication
Strategies to improve adherence to antihypertensive medication
 
Hta basic introduction
Hta basic introductionHta basic introduction
Hta basic introduction
 

More from Marion Sills

Measuring and Enhancing Your Academic Medical Impact
Measuring and Enhancing Your Academic Medical ImpactMeasuring and Enhancing Your Academic Medical Impact
Measuring and Enhancing Your Academic Medical Impact
Marion Sills
 
Social Media for CU's Division of Pediatric Emergency Medicine
Social Media for CU's Division of Pediatric Emergency MedicineSocial Media for CU's Division of Pediatric Emergency Medicine
Social Media for CU's Division of Pediatric Emergency Medicine
Marion Sills
 
Adding Social Determinant Data Changes Children’s Hospitals’ Readmissions Per...
Adding Social Determinant Data Changes Children’s Hospitals’ Readmissions Per...Adding Social Determinant Data Changes Children’s Hospitals’ Readmissions Per...
Adding Social Determinant Data Changes Children’s Hospitals’ Readmissions Per...
Marion Sills
 
ED abdominal pain lecture
ED abdominal pain lectureED abdominal pain lecture
ED abdominal pain lecture
Marion Sills
 
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...
Marion Sills
 
2015 0128 SAFTINet Research & Quality Improvement Quarterly Meeting.
2015 0128 SAFTINet Research & Quality Improvement Quarterly Meeting.2015 0128 SAFTINet Research & Quality Improvement Quarterly Meeting.
2015 0128 SAFTINet Research & Quality Improvement Quarterly Meeting.
Marion Sills
 
2014 0423 rqi meeting uds 2.0 and convocation project ideas
2014 0423 rqi meeting uds 2.0 and convocation project ideas2014 0423 rqi meeting uds 2.0 and convocation project ideas
2014 0423 rqi meeting uds 2.0 and convocation project ideas
Marion Sills
 
Practice Variability in and Correlates of Patient-Centered Medical Home Chara...
Practice Variability in and Correlates of Patient-Centered Medical Home Chara...Practice Variability in and Correlates of Patient-Centered Medical Home Chara...
Practice Variability in and Correlates of Patient-Centered Medical Home Chara...
Marion Sills
 
SAFTINet CER Asthma Protocol
SAFTINet CER Asthma ProtocolSAFTINet CER Asthma Protocol
SAFTINet CER Asthma Protocol
Marion Sills
 
CEMRC H1N1 Presentation 20100614
CEMRC H1N1 Presentation 20100614CEMRC H1N1 Presentation 20100614
CEMRC H1N1 Presentation 20100614
Marion Sills
 
SAFTINet Overview for EDRC
SAFTINet Overview for EDRCSAFTINet Overview for EDRC
SAFTINet Overview for EDRC
Marion Sills
 
Patient-reported outcomes for asthma in children and adults
Patient-reported outcomes for asthma in children and adultsPatient-reported outcomes for asthma in children and adults
Patient-reported outcomes for asthma in children and adults
Marion Sills
 
Implementing Point-of-Care PROMs
Implementing Point-of-Care PROMsImplementing Point-of-Care PROMs
Implementing Point-of-Care PROMs
Marion Sills
 
Pec cv pro workgroup 3 21 12
Pec cv pro workgroup 3 21 12Pec cv pro workgroup 3 21 12
Pec cv pro workgroup 3 21 12
Marion Sills
 
ACT Implementation in SAFTINet
ACT Implementation in SAFTINetACT Implementation in SAFTINet
ACT Implementation in SAFTINet
Marion Sills
 
Cv pro overview 2 may 2012
Cv pro overview 2 may 2012Cv pro overview 2 may 2012
Cv pro overview 2 may 2012
Marion Sills
 
Cer safti net overview edrc 1 feb 2011
Cer safti net overview edrc 1 feb 2011Cer safti net overview edrc 1 feb 2011
Cer safti net overview edrc 1 feb 2011
Marion Sills
 
Pec research overview 19 jan2011
Pec research overview 19 jan2011Pec research overview 19 jan2011
Pec research overview 19 jan2011
Marion Sills
 
Data validation 12 sept 2011
Data validation 12 sept 2011Data validation 12 sept 2011
Data validation 12 sept 2011
Marion Sills
 
Edm site visit slides sills
Edm site visit slides sillsEdm site visit slides sills
Edm site visit slides sills
Marion Sills
 

More from Marion Sills (20)

Measuring and Enhancing Your Academic Medical Impact
Measuring and Enhancing Your Academic Medical ImpactMeasuring and Enhancing Your Academic Medical Impact
Measuring and Enhancing Your Academic Medical Impact
 
Social Media for CU's Division of Pediatric Emergency Medicine
Social Media for CU's Division of Pediatric Emergency MedicineSocial Media for CU's Division of Pediatric Emergency Medicine
Social Media for CU's Division of Pediatric Emergency Medicine
 
Adding Social Determinant Data Changes Children’s Hospitals’ Readmissions Per...
Adding Social Determinant Data Changes Children’s Hospitals’ Readmissions Per...Adding Social Determinant Data Changes Children’s Hospitals’ Readmissions Per...
Adding Social Determinant Data Changes Children’s Hospitals’ Readmissions Per...
 
ED abdominal pain lecture
ED abdominal pain lectureED abdominal pain lecture
ED abdominal pain lecture
 
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...
Stakeholder Engagement in a Patient-Reported Outcomes Implementation by a Pra...
 
2015 0128 SAFTINet Research & Quality Improvement Quarterly Meeting.
2015 0128 SAFTINet Research & Quality Improvement Quarterly Meeting.2015 0128 SAFTINet Research & Quality Improvement Quarterly Meeting.
2015 0128 SAFTINet Research & Quality Improvement Quarterly Meeting.
 
2014 0423 rqi meeting uds 2.0 and convocation project ideas
2014 0423 rqi meeting uds 2.0 and convocation project ideas2014 0423 rqi meeting uds 2.0 and convocation project ideas
2014 0423 rqi meeting uds 2.0 and convocation project ideas
 
Practice Variability in and Correlates of Patient-Centered Medical Home Chara...
Practice Variability in and Correlates of Patient-Centered Medical Home Chara...Practice Variability in and Correlates of Patient-Centered Medical Home Chara...
Practice Variability in and Correlates of Patient-Centered Medical Home Chara...
 
SAFTINet CER Asthma Protocol
SAFTINet CER Asthma ProtocolSAFTINet CER Asthma Protocol
SAFTINet CER Asthma Protocol
 
CEMRC H1N1 Presentation 20100614
CEMRC H1N1 Presentation 20100614CEMRC H1N1 Presentation 20100614
CEMRC H1N1 Presentation 20100614
 
SAFTINet Overview for EDRC
SAFTINet Overview for EDRCSAFTINet Overview for EDRC
SAFTINet Overview for EDRC
 
Patient-reported outcomes for asthma in children and adults
Patient-reported outcomes for asthma in children and adultsPatient-reported outcomes for asthma in children and adults
Patient-reported outcomes for asthma in children and adults
 
Implementing Point-of-Care PROMs
Implementing Point-of-Care PROMsImplementing Point-of-Care PROMs
Implementing Point-of-Care PROMs
 
Pec cv pro workgroup 3 21 12
Pec cv pro workgroup 3 21 12Pec cv pro workgroup 3 21 12
Pec cv pro workgroup 3 21 12
 
ACT Implementation in SAFTINet
ACT Implementation in SAFTINetACT Implementation in SAFTINet
ACT Implementation in SAFTINet
 
Cv pro overview 2 may 2012
Cv pro overview 2 may 2012Cv pro overview 2 may 2012
Cv pro overview 2 may 2012
 
Cer safti net overview edrc 1 feb 2011
Cer safti net overview edrc 1 feb 2011Cer safti net overview edrc 1 feb 2011
Cer safti net overview edrc 1 feb 2011
 
Pec research overview 19 jan2011
Pec research overview 19 jan2011Pec research overview 19 jan2011
Pec research overview 19 jan2011
 
Data validation 12 sept 2011
Data validation 12 sept 2011Data validation 12 sept 2011
Data validation 12 sept 2011
 
Edm site visit slides sills
Edm site visit slides sillsEdm site visit slides sills
Edm site visit slides sills
 

Recently uploaded

Common Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptxCommon Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptx
patriciaava1998
 
Pediatric Emergency Care for Children | Apollo Hospital
Pediatric Emergency Care for Children | Apollo HospitalPediatric Emergency Care for Children | Apollo Hospital
Pediatric Emergency Care for Children | Apollo Hospital
Apollo 24/7 Adult & Paediatric Emergency Services
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DR Jag Mohan Prajapati
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
Dr Rachana Gujar
 
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSONNEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
SHAMIN EABENSON
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
Brian Frerichs
 
Bath patient Fundamental of Nursing.pptx
Bath patient Fundamental of Nursing.pptxBath patient Fundamental of Nursing.pptx
Bath patient Fundamental of Nursing.pptx
MianProductions
 
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdfchatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
marynayjun112024
 
FACIAL NERVE
FACIAL NERVEFACIAL NERVE
FACIAL NERVE
aditigupta1117
 
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
gjsma0ep
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
Azreen Aj
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
VITASAuthor
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Ear Solutions (ESPL)
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
eurohealthleaders
 
Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.
Vishal kr Thakur
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
Chandrima Spa Ajman
 
Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
Dharma Homoeopathy
 
LEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptxLEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptx
ChetanSharma78255
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
Vishal kr Thakur
 
2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers
Conference Panel
 

Recently uploaded (20)

Common Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptxCommon Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptx
 
Pediatric Emergency Care for Children | Apollo Hospital
Pediatric Emergency Care for Children | Apollo HospitalPediatric Emergency Care for Children | Apollo Hospital
Pediatric Emergency Care for Children | Apollo Hospital
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
 
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSONNEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
 
Bath patient Fundamental of Nursing.pptx
Bath patient Fundamental of Nursing.pptxBath patient Fundamental of Nursing.pptx
Bath patient Fundamental of Nursing.pptx
 
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdfchatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
 
FACIAL NERVE
FACIAL NERVEFACIAL NERVE
FACIAL NERVE
 
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
 
Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
 
Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
 
LEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptxLEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptx
 
Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.Hypertension and it's role of physiotherapy in it.
Hypertension and it's role of physiotherapy in it.
 
2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers2024 HIPAA Compliance Training Guide to the Compliance Officers
2024 HIPAA Compliance Training Guide to the Compliance Officers
 

Med adherence 2 july 2012

  • 1. + SAFTINet Cardiovascular Cohort PRO: Medication Adherence CER Team 2 July 2012
  • 2. + Overview  PEC preference regarding the medication adherence measure  Instrument  Pilot test  Feedback on the instrument  Feedback on the pilot  How would we use the findings in our research?
  • 3. + Overview  PEC preference regarding the medication adherence measure  Instrument  Pilot test  Feedback on the instrument  Feedback on the pilot  How would we use the findings in our research?
  • 4. + Proposed Med Adherence Instrument and Pilot Test  A single medication adherence question (derived from the Gehi question) and a single checklist of barriers  Pilot test by 1-2 providers in each organization for a few weeks
  • 5. + Proposed Med Adherence Instrument: Adherence Question  Patient Instructions:  It can be difficult to take all of our medications as the doctor has told us to. Please tell us how often taking your medications is difficult for you.  In the past month, how often did you take your medications as the doctor or provider prescribed?1 Please check one (1) answer.  “All of the time” (100%)  “Nearly all of the time” (90%)  “Most of the time” (75%)  “About half the time” (50%)  “Less than half the time” (<50%)  “None of the time” (0%)
  • 6. + Proposed Med Adherence Instrument: Barriers Checklist  In the past month, why have you not taken your medicine as your doctor prescribed? Check all that apply.  My medicine makes me feel bad (I have “side effects”). Please describe: ________________  I don’t feel like my medicine is working  I feel like taking my medicine will not improve my health  There are too many doses of medicine to take each day  I cannot afford my medicine  I forget to take my medicine
  • 7. + Proposed Med Adherence Instrument: Barriers Checklist  Domains for Barriers:  Side effects  No improvement in symptoms  Belief medication won’t change outcomes  Complexity of regimen  Financial cost  Forgetting  Some options for wording on next slides
  • 8. + Proposed Med Adherence Instrument: Barriers Checklist  Domain for Barriers: Side effects  Options  proposed: My medicine makes me feel bad (I have “side effects”). Please describe: ________________  ASK-12: Have you skipped or stopped taking a medicine because it made you feel bad?  Morisky-8: Have you ever cut back or stopped taking your medicine without telling your doctor because you felt worse when you took it?  Morisky-4: At times, if you feel worse if you take your medicines, do you stop taking them?
  • 9. + Proposed Med Adherence Instrument: Barriers Checklist  Domain for Barriers: No improvement in symptoms  Options  proposed: I don’t feel like my medicine is working  ASK-12:  I feel confident that each one of my medicines will help me  Have you skipped or stopped taking a medicine because you did not think it was working?
  • 10. + Proposed Med Adherence Instrument: Barriers Checklist  Domain for Barriers: Belief medication won’t change outcomes  Options  proposed: I feel like taking my medicine will not improve my health  ASK-12:  I feel confident that each one of my medicines will help me  Have you skipped or stopped taking a medicine because you did not think it was working?
  • 11. + Proposed Med Adherence Instrument: Barriers Checklist  Domain for Barriers: Complexity of regimen  Options  proposed: There are too many doses of medicine to take each day  ASK-12: Taking medicines more than once a day is inconvenient
  • 12. + Proposed Med Adherence Instrument: Barriers Checklist  Domain for Barriers: Financial cost  Options  proposed: I cannot afford my medicine  ASK-12:  I feel confident that each one of my medicines will help me  Have you skipped, stopped, not refilled, or taken less medicine because of the cost?
  • 13. + Proposed Med Adherence Instrument: Barriers Checklist  Domain for Barriers: Forgetting  Options  proposed: I forget to take my medicine  ASK-12:  I just forget to take my medicines some of the time  I run out of my medicine because I don’t get refills on time  Morisky-8:  Do you sometimes forget to take your pills?  How often do you have difficulty remembering to take all your medications?  When you travel or leave home do you sometimes forget to bring your medicine?  Morisky-4: Have you ever forgotten to take your medicine?
  • 14. + Med Adherence Instrument: Provider Guidance, 1st slide  Provider Instructions: Please review the patient’s responses and considering adjusting the treatment plan if patients exhibit difficulty taking their medications. Encouraging adherence to medications is one of the best ways to improve outcomes! Some ideas for helping patients take their medications include:  Side effects: Switch medications, adjust the dose, or recommend other mitigation strategies (e.g., taking the medication with food, reducing salt intake)  Feeling as though the medication does not or will not improve their health: indicate a range of time before seeing results, encourage logging or home monitoring (e.g., blood pressure) so patients can see change
  • 15. + Med Adherence Instrument: Provider Guidance, 2nd slide  Complex regimens: Consider reducing medications, use combination therapies, design a treatment plan that is easier to follow (e.g., all medications should be taken in the morning), use organizing systems (pillboxes)  Cost: Switch to lower cost medications, facilitate sign-up for prescription assistance plans  Forgetting: Encourage routines, pairing medications with other daily activities, use of memory aids (alarms, pillboxes, calendars), use health IT tools to remind patients to proactively refill prescriptions
  • 16. + Pilot Timeline  July 10, 2012: Feedback from PEC partners on summary of the instrument  July 20, 2102: Spanish translation of instrument completed  July 20, 2012: Partners’ providers for Pilot Test identified  Aug 1, 2012: PEC and providers participating in Pilot meet at regularly scheduled PEC meeting  Aug 1, 2012: Feedback questionnaires provided to PEC partners  Aug 13, 2012: Feedback questionnaires returned to SAFTINet research team
  • 17. + Pilot Survey, 1st slide  Is the information in the survey useful to you as a clinical provider? Are there questions that are not useful? Are there questions that would be really useful to you that are missing?  Do the respondents feel comfortable answering the questions?  Is the wording of the survey clear? Are there questions that respondents consistently misunderstand? Is there some wording that needs to be changed? Do you have suggestions for better wording?  How long does this survey take to administer?
  • 18. + Pilot Survey, 2nd slide  Is the survey too long? If so, what question(s) do you suggest we drop? Is there a question we are missing?  Are the “provider instructions” about how to adjust the treatment plan helpful to you? Are they too common-sense? Are they too context-dependent (would be different at different practice sites)?  Did it make sense to administer this survey at the patient’s visit to the clinic? Would it be better administered by phone or by other strategies? If so, how do you suggest we administer it?  Do you prefer to administer the survey to all patients? To only patients with hyperlipidemia or hypertension?
  • 19. + Overview  PEC preference regarding the medication adherence measure  Instrument  Pilot test  Feedback on the instrument  Feedback on the pilot  How would we use the findings in our research?
  • 20. + Overview  PEC preference regarding the medication adherence measure  Instrument  Pilot test  Feedback on the instrument  Feedback on the pilot  How would we use the findings in our research?
  • 21. + Research Utility  Which domains would we use?  medication adherence scale  barriers measure total count, or focus on specific barrier(s)  How would we use these in an analytic model? PCMH Medication adherence Barriers Disease control

Editor's Notes

  1. data completeness—how many will fill this out? If we look at med adherence as an outcome of PCMH we could just look at those with med adherence data To look at the whole framework here is very complicated—this is a path analysis. Not sure there’s a good way to do it to account for clustering. you would need to use average med adherence on the practice level